Skip to main content

Table 1 Table shows VSSS-MT Treatment satisfaction score among respondents

From: Client satisfaction to methadone maintenance treatment program in Myanmar

Respondent characters

Sub groups

Number (n)

Total VSSS-MT score (SD)

p value

Methadone dose categories

less than or equal 80 mg

more than 80 mg

132

76

98.61 (13.97)

103.11 (14.28)

0.0276**

Methadone duration

less than or equal 2.4 years

more than 2.4 years

120

89

100.83 (14.40)

99.40 (13.93)

0.4755

Methadone treat time

First time treatment

More than first time

173

35

101.34 (13.95)

94.74 (14.46)

0.0120**

• less than or equal 80 mg

First time treatment

More than first time

109

22

100.03 (13.45)

91.54 (14.96)

0.0091**

• more than 80 mg

First time treatment

More than first time

63

13

103.71 (14.67)

100.15 (12.27)

0.4167

• less than or equal 2.4 years

First time treatment

More than first time

95

24

102.68 (13.52)

93.54 (15.98)

0.0052

• more than 2.4 years

First time treatment

More than first time

78

11

99.69 (14.37)

97.36 (10.61)

0.6067

HIV status (HIV)

Not infected

Infected

126

74

99.23 (13.84)

102.35 (14.81)

0.1351

Hepatitis C status (HCV)

Not infected

Infected

77

71

103.21 (13.35)

98.66 (14.03)

0.0452**

Hepatitis B status (HBV)

Not infected

Infected

166

15

101.14 (14.04)

101.73 (12.19)

0.8754

Tuberculosis (TB) treatment history

Not treated

Treated

147

54

100.92 (13.71)

100.65 (14.00)

0.9021

Sexually Transmitted infection (STI) history

Not infected

Infected

164

45

100.06 (13.69)

100.80 (16.01)

0.7577

Age

Younger and equal 35 years

Older than 35 years

128

81

100.82 (14.43)

99.27 (13.82)

0.4433

Body Mass Index (BMI)

Less than mean BMI (20.5)

More than mean BMI

122

84

100.33 (14.87)

100.48 (13.06)

0.9412

Currently on antiretroviral therapy (ART)

No

On treatment

141

68

99.08 (13.53)

102.59 (15.29)

0.0938

Education

Up to primary

More than primary

48

161

104.77 (15.35)

98.86 (13.58)

0.0110**

Recent work

Unemployed

Employed

24

182

96.95 (15.41)

100.93 (13.81)

0.1926

Current Peer/ Outreach

No

Peer/outreach

180

29

100.52 (14.27)

98.38 (13.77)

0.4528

ASI for Employment

Low score

High score

102

104

99.39 (13.39)

100.83 (15.06)

0.4711

ASI for Alcohol Use

Low score

High score

28

36

105.96 (10.96)

102.22 (14.48)

0.2600

ASI for Drug Use

Low score

High score

162

47

100.96 (14.21)

97.66 (13.97)

0.1604

ASI for Legal Status

Low score

High score

14

14

101.64 (15.57)

94.29 (10.86)

0.1590

ASI for Family/ Social Status

Low score

High score

139

70

100.90 (13.71)

98.87 (15.09)

0.3306

Marital status

Currently married

Single/separated

84

122

98.62 (14.51)

101.48 (14.01)

0.1568

Income

Lower (than average)

Higher

131

77

99.65 (14.97)

101.18 (12.89)

0.4542

Current marital status satisfaction

Not satisfied

Satisfied

20

189

96.65 (19.01)

100.60 (13.59)

0.2375

WHO Quality of life (QOL) total score

Low

High

88

121

93.63 (14.42)

105.02 (11.96)

0.0001***

Physical QOL score

Low

High

53

156

88.94 (15.06)

104.05 (11.65)

0.0001***

Psychological QOL score

Low

High

41

168

91.07 (15.32)

102.45 (12.99)

0.0001***

Social QOL score

Low

High

71

138

94.86 (15.47)

102.98 (12.68)

0.0001***

Environmental QOL score

Low

High

54

155

90.81 (14.83)

103.50 (12.42)

0.0001***

Current leisure status satisfaction

Not satisfied

Satisfied

29

180

92.38 (16.59)

101.48 (13.39)

0.0012**

• Current leisure status with family

Not satisfied

Satisfied

119

90

100.03 (14.27)

100.48 (14.15)

0.8200

• Current leisure status with friend

Not satisfied

Satisfied

135

74

99.52 (14.76)

101.50 (13.08)

0.3354

• Current leisure status alone

Not satisfied

Satisfied

159

50

101.09 (13.71)

97.44 (15.42)

0.1123

Abuse encountered within 30 days

•  Psychological abuse

Not experienced

Experienced

183

22

100.01 (13.91)

101.05 (16.64)

0.7474

•  Physical abuse

Not experienced

Experienced

203

1

100.10 (14.26)

102.00 (.)

.

•  Sexual abuse

Not experienced

Experienced

204

1

100.07 (14.20)

111.00 (.)

.

Urine illicit substance findings

•  Urine Morphine

Absent

Present

93

116

100.62 (14.13)

99.90 (14.29)

0.7137

•  Urine Tetrahydrocannabinol (THC)

Absent

Present

185

24

100.42 (14.40)

98.71 (12.59)

0.5802

•  Urine Methamphetamine

Absent

Present

158

51

100.93 (14.62)

98.02 (12.65)

0.2034

•  Urine Amphetamine

Absent

Present

191

18

100.19 (14.50)

100.56 (10.55)

0.9167

•  Urine Benzodiazepine

Absent

Present

137

72

100.84 (14.95)

99.04 (12.62)

0.3853

Last heroin injection within 30 days

No

Yes

93

115

102.35 (14.15)

98.44 (14.08)

0.0483**

Frequency of injection

No or few injections (mean = 7)

Higher

96

112

102.46 (13.64)

98.35 (14.48)

0.0373**

Needle sharing within 30 days

Not shared

Shared

99

4

99.21 (15.26)

102.00 (1.41)

0.7169

Life time sharing of needle and syringes

Not shared

Shared

106

102

98.72 (12.66)

101.58 (15.47)

0.1452

  1. Independent t-test p value: ** significance < 0.05, *** significance < 0.001
  2. Table explanation: This table explains the result of the significant difference of the total score of the VSSS-MT questionnaire with the respondent characteristics